Crossmark

Molecular insight into chymotrypsin inhibitor 2 resisting proteolytic degradation

Crossref DOI link: https://doi.org/10.1039/C8CP07784C

Published Online: 2019

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Wei, Wanqing

Chen, Yani

Xie, Daiqian https://orcid.org/0000-0001-7185-7085
Zhou, Yanzi https://orcid.org/0000-0002-2097-9186
Funding

Funding for this research was provided by:

Natural Science Foundation of Jiangsu Province (BK20171333)

National Natural Science Foundation of China (21203090, 21590802, 21733006)
License Information

Accepted Manuscript valid from 2020-01-30
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Daiqian Xie (ORCID)

: Yanzi Zhou (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 21 December 2018; Accepted 29 January 2019; Accepted Manuscript published 30 January 2019; Advance Article published 14 February 2019; Version of Record published 27 February 2019